... the BMBF VPM was able to licence the novel tuberculosis vaccine from the Max Planck Institute for Infection Biology. ... live-vaccine worldwide: Bacille Calmette-Guérin (BCG). However, BCG often fails to ...
... of Leukocyte Biology (http://www.jleukbio.org) may lead to improvements in the efficacy of the current tuberculosis vaccine. Specifically, a team of Italian researchers discovered a new role for type ...
... enduring mysteries – namely, why the once-effective tuberculosis vaccine no longer prevents the bacterial lung ... against other pathogens.
The current TB vaccine, known as BCG (bacille Calmette-Guérin), ...
A novel aerosol version of the most common tuberculosis (TB) vaccine, administered directly to the lungs as an oral mist, offers significantly better protection against the disease in experimental ...
... a recombinant vaccine holds promise in being able to better protect people from tuberculosis. This vaccine will not be tested further because it uses an antibiotic resistant gene that scientists want ...
...
"Tuberculosis is of the biggest concern to people with HIV. At the same time, the only existing tuberculosis vaccine, BCG, should not be used in people with HIV, because it poses a health risk by ...
A breakthrough strategy to improve the effectiveness of the only tuberculosis vaccine approved for humans provided superior protection against the deadly disease in a pre-clinical test, report ...
A breakthrough strategy to improve the effectiveness of the only tuberculosis vaccine approved for humans provided superior protection against the deadly disease in a pre-clinical test.
(PhysOrg.com) -- The world`s leading candidate for a tuberculosis vaccine, developed at the University of Oxford, is to enter Phase IIb proof-of-concept clinical trials, making it the first TB ...
The world's leading candidate for a tuberculosis vaccine is to enter Phase IIb proof-of-concept clinical trials, making it the first TB candidate vaccine for more than 80 years to get to this advanced ...
... mysteries – what happened to the tuberculosis vaccine. The once-effective vaccine no longer prevents ... antioxidant-producing capacity might improve the vaccine.
"Our idea to take something away from BCG ...
... medicine's enduring mysteries -- what happened to the tuberculosis vaccine. The once-effective vaccine no longer prevents the bacterial lung infection that kills more than 1.7 million ...
GENEVA (AP) -- The World Health Organization says a study has shown that babies with HIV could die if given a standard tuberculosis vaccine....
... Local differences in this system in humans might partly explain the variable success rate of Tuberculosis vaccination programmes around the world."
One way to make a good vaccine even more effective ...
... Medicine.
"The panel recognised that many new and diverse tuberculosis vaccines are currently under development," says the lead ... vaccine trials: WHO panel recommendations. PLoS Med 5(7): e145. doi:10 ...
